Navigation Links
New Nutraceutical Supplement Provides Simplified Approach to Diabetes Management Programs

CARMEL, Ind., Oct. 24 /PRNewswire/ --

Less complicated

The introduction of Diabatrol(TM), a promising new product, will come as a welcome relief to Type II diabetic and pre-diabetic patients who've experienced intense frustrations over the complications of caring for the disease and the discomfort of daily glucose management regimes.

A recent study, conducted by researchers at University of Chicago that included adult patients living with diabetes, highlighted the problems associated with diabetes care and the need for the elimination of some of its treatment complications. The daily diabetes management programs often prescribed were found to be complicated and difficult for many respondents. "An important minority of patients believe that comprehensive diabetes treatment programs have a significant impact on quality of life that is comparable to that of life with (diabetes) complications. We did not know that such a large proportion of patients would report this," reported lead author Dr. Elbert Huang to Reuters Health.

The product

The new product Diabatrol, a performance-proven nutraceutical supplement produced by Diabco Life Sciences in Carmel, Indiana, works by helping to reduce oxidative stress and insulin resistance, two key concerns for Type II diabetics and pre-diabetics. Not a prescription pharmaceutical, Diabatrol is a nutritionally balanced, gluten-free, low glycemic, hypoallergenic neutraceutical that contains more than 80 antioxidants from whole grain derivatives. Consuming Diabatrol is a simple act of opening a small pouch containing the water soluble product, mixing it with a favorite beverage, and consuming it twice a day. The desired result for patients is more balanced overall nutrition and a convenient, simplified approach to managing a blood glucose metabolism and helping reduce the complications associated with the daily routines of diabetes management. A typical diabetes patient often takes several medications each day, including two or three different pills to control blood sugar levels, one or two to lower cholesterol, two or more to reduce blood pressure and a daily aspirin to prevent blood clots.

Strong test results

The active ingredients in Diabatrol's proprietary formulation are whole grain derivatives that have been clinically tested and documented to lower blood glucose levels and reduce insulin resistance. In a 60-day, double-blind, randomized trial, which have been published in the Journal of Nutritional Biochemistry, the results were very promising: Type II diabetes test subjects realized an average 32.9 percent reduction (52 points) in fasting blood glucose levels. These results are comparable to many pharmaceutical drugs. In addition, an impressive secondary result included an 8 percent reduction in low-density lipoprotein (LDL), an important consideration for diabetic at-risk individuals concerned with high blood pressure and heart problems.

Encouraging news

Considering Diabatrol's positive showing thus far in decreasing insulin resistance and providing a balanced level of overall nutrition, every indication is that this product provides a positive answer for a more simplified approach to the daily routines associated with diabetes management programs.

Diabco Life Sciences, LLC

The company's mission is to provide effective neutraceutical supplements for consumers seeking performance proven non-prescription alternatives to help mitigate specific health risks. Diabco Life Sciences strives to combine advanced science, nutrition and good manufacturing practices to bring clinically tested and scientifically documented products to market for meeting the daily healthcare needs of individuals. More information about the company can be found at, or by writing to Diabco Life Sciences, 484 East Carmel Drive, #204, Carmel, Indiana, 46032.

SOURCE Diabatrol
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Iron supplementation for a common side effect
2. B Vitamin Supplementatoin Saves Money and Lives
3. Iron supplements proves helpful in dry cough .
4. Taking Vitamin Supplements With Caution
5. Supplement helps cardiac surgery
6. Zinc supplements improve survival rate
7. Mislabeled Body-building Steroid Supplements
8. Garlic Supplements Impede HIV Therapy
9. Lactobacillus Supplements shorten the duration of diarrhoea
10. Iron supplementation quite necessary
11. Supplements for Ear Infections
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap ... and Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s ... STEMI and Sepsis conditions present in similar ways and require time-critical intervention to avoid ...
(Date:11/26/2015)... ON and Cambridge, ON (PRWEB) , ... November ... ... today the availability of a real-time eReferral system for diagnostic imaging in the ... ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic medical ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare ... participated in the 61st annual Employee Benefits Conference. The Employee Benefits Conference was ... November 8th through Wednesday, November 11th, 2015. The conference was held at the ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... Water For Empowerment ™ attracts volunteers together who want to combine talents ... women as key stakeholders in the process. The non-profit launched its first major ...
(Date:11/25/2015)... ... 2015 , ... Dr. John Pierce, Medical Director at the Ageless Forever clinic ... the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, the Capillus272 ... need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro is a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... report to their offering. --> Research ... addition of the "Self Administration of High ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the European Cell Surface Marker ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology: